INTRODUCTION
A fundamental question about transmembrane receptors is whether extracellular ligand binding architecture can influence the nature of receptor activation. This is especially pertinent to the ability of ab T cell antigen receptors (TCR) to sense and differentially respond to the universe of peptides presented by major histocompatibility complex (MHC) . T cell activation is initiated by TCR engagement of peptides displayed upon MHC (pMHC), but subsequent signaling is the product of a complex series of events involving the TCR-associated CD3, CD4, and CD8 coreceptors and assembly into multimeric clusters that ultimately stimulate phosphorylation of intracellular immunoreceptor tyrosine-based activation motifs (ITAMs) (Beddoe et al., 2009; Gil et al., 2002; Kuhns et al., 2006 ; van der Merwe and Dushek, 2011; Wucherpfennig et al., 2010) . Given the wide range of TCR binding geometries to peptide-MHC (pMHC) seen in TCRpMHC complexes that fall within the limits of a loosely conserved docking orientation (Hahn et al., 2005; Rudolph et al., 2006) , it has so far appeared that a pMHC binding event of sufficient affinity and duration can induce signaling regardless of the TCR-pMHC complex architecture. Furthermore, the lack of correlation between TCR-pMHC structural differences and the type of T cell signals induced implies that different TCR-pMHC binding modes do not generate distinct cellular signals (Ding et al., 1999) .
It is clear that the chemistry of pMHC recognition by the TCR does influence signaling by virtue of its effect on the binding kinetics, half-life, affinity, and other biophysical parameters (Alam et al., 1996; Kersh et al., 1998; Qi et al., 2006) . A single thermodynamic or kinetic parameter can sometimes qualitatively correlate with T cell responses (Aleksic et al., 2010; Govern et al., 2010) , and recent methodologies accounting for receptor confinement and 2D receptor kinetics in the membrane have shown correlations with activation (Huang et al., 2010; Huppa et al., 2010) . It is also generally accepted that clustering of the TCR is critical for T cell activation within the immune synapse, as pMHC multimers are required for signaling in ab T cells (Bromley et al., 2001; van der Merwe and Cordoba, 2011) . Bivalent TCR and CD3 antibodies can substitute for pMHC to induce T cell responses through clustering. Importantly, however, not all TCR-CD3-specific antibodies stimulate T cells equally, suggesting that the receptor geometry required for full activation may not be completely permissive (Janeway, 1995; Yoon et al., 1994) , as has been proposed (Cochran et al., 2001) .
The TCR-pMHC docking geometry has been extensively studied in an effort to understand MHC restriction (Garcia et al., 2009; Godfrey et al., 2008; Marrack et al., 2008; Wilson and Stanfield, 2005; Wucherpfennig et al., 2009) . The compendium of complex structures has revealed a loosely conserved docking paradigm, or binding footprint. TCRs bind pMHC roughly on a diagonal with the TCR Vb complementarity determining regions (CDRs) positioned over the MHC a1 helix and peptide C terminus and the TCR Va CDRs positioned over the MHC a2 (class I) or b1 (class II) helix or peptide N terminus, thereby polarizing the TCR orientation on the MHC surface (Garcia and Adams, 2005) . There is a wide range (± $100
) of docking angles that conform to this canonical docking polarity. That such a range of docking angles can support TCR signaling suggests that any constraints on signaling imposed by the geometry of TCR-pMHC engagement are either quite loose or nonexistent.
The conservation of a TCR-MHC docking topology could be a product of coevolved TCR-MHC germline specificity , a consequence of extrinsic factors such as coreceptor steric influences (Buslepp et al., 2003; Collins and Riddle, 2008) , or a product of CDR3-mediated peptide selection during thymic education (Huseby et al., 2005) . Recent evidence supports the idea of a coevolved germline specificity as an important determinant of the TCR-MHC binding mode Feng et al., 2007; Newell et al., 2011; Rubtsova et al., 2009; Scott-Browne et al., 2009) . In particular, a series of structural and functional studies of the widely used murine Vb8.2 germline segment showed that a similar set of TCR-MHC interfacial contacts are formed, which probably represent the evolutionary signature of TCR-MHC coevolution and appear to play a role in orienting the TCR docking footprint on the MHC Feng et al., 2007; Garcia et al., 2009 ). An alternative view is that coreceptors bias the TCR for pMHC recognition and that TCRs can also recognize non-MHC antigens (Van Laethem et al., 2007) .
A related issue is how TCRs crossreact with the universe of different peptide antigens they encounter during thymic selection and peripheral surveillance (Felix and Allen, 2006; Mason, 1998) . Although we know that peptides have different potencies to activate TCR signaling, we do not know whether peptide crossreactivity is achieved through a single docking footprint or whether a range of MHC docking modes exist that would have disparate impacts on signaling induced by each peptide (Felix et al., 2007; Yin and Mariuzza, 2009) . Although crossreactive TCR complexes so far have shown similar docking modes , in many cases the peptides shared key TCR contact residues (Ding et al., 1999; Macdonald et al., 2009; , leaving open the question of how sequences of unrelated peptides are accommodated by the TCR.
Here we address the roles of TCR-pMHC binding geometry, interface chemistry, affinity and kinetics in TCR signaling. We describe the development of pMHC libraries in yeast that allowed us to discover large collections of peptides reactive with a given TCR. We measured the 2D and 3D interaction parameters with four different peptides, assayed signaling properties, and determined the crystal structures of the complexes. Our results suggest that there are geometric constraints on TCR-MHC docking footprints compatible with signaling and, more generally, TCR signaling can be modulated by perturbations in the extracellular receptor-ligand architecture.
RESULTS

42F3 versus 2C Recognition of H2-L d Presenting the QL9 Peptide
The 42F3 TCR is derived from an alloreactive cytotoxic T lymphocyte clone that recognizes the class I MHC molecule H2-L d presenting the peptide p2Ca 933-940 of endogenous mouse 2-oxoglutarate dehydrogenase (Accession NP_035086) (Hornell et al., 1999) . 42F3 is related to another p2Ca-H2-L d reactive TCR, 2C, whose structure and binding properties have been extensively investigated (Colf et al., 2007; Garcia et al., 1996; Holler et al., 2003; Sykulev et al., 1994) . Both 42F3 and 2C also recognize the related nonamer epitope of 2-oxogluterate dehydrogenase, QL9. The variable domains of 42F3 are Va3.3 and Vb8.3 and therefore encode identical CDR1a and CDR2a and nearly identical CDR1b and CDR2b to 2C ( Figure 1A ). However, 42F3 and 2C use different CDR3 sequences to recognize QL9-H2-L d ( Figure 1A ). Thus, these two TCR represent an ideal pair to ask whether shared germline contacts would persist despite their distinct CDR3-peptide contacts.
We solved the crystal structure of a 42F3 single-chain (sc) Fv in complex with QL9-H2-L d to 2.75Å resolution and found that it shared a highly similar overall binding footprint compared to the structure of 2C-QL9-H2-L d ( Figure 1B and Table S1 , available online) (Colf et al., 2007) , and Va binding contacts are much more similar than Vb ( Figure 1C ). The Va3s in both TCRs use a nearly identical set of contacts involving Tyr31a, Lys48a, Tyr50a, Ser51a, and Gly52a to contact the H2-L d a2 helix at Glu154 and Tyr155 ( Figure 1D ). In both interfaces, Ser51a hydrogen bonds to the MHC a2 helix backbone through its side-chain hydroxyl, whereas Tyr31a and Tyr50a bury Tyr155 on the MHC surface ( Figure 1D ). For Vb8.2 and Vb8.3, the 2C and 42F3 contacts with H2-L d were highly divergent from one another ( Figure 1D ). In both TCRs, Asn30b and Tyr50b make contacts to the a1 helix, but the specific pair-wise residue contacts were different ( Figure 1D ).
Identification of New 42F3-Reactive Peptides
We developed a method to screen for 42F3 binding to yeastdisplayed peptide-H2-L d libraries ( Figure 2A and Figure S1 ). A variant of the ''mini-MHC'' platform, previously used for biophysical studies (Colf et al., 2007; Jones et al., 2006) , was fused through a Gly-Ser linker to the N terminus of a nonamer peptide. In order to accommodate the Gly-Ser linker without disrupting TCR binding, we introduced a knob-to-hole mutation (Trp167 to Ala) at the end of the MHC a2 helix that created a notch for the linker. The sc peptide-H2-L d complexes were fused to the C terminus of the yeast Aga2 protein (Gai and Wittrup, 2007) (Figure 2A) . Key to this strategy is that selections are based on direct binding, in a cell-free system with recombinant TCR, devoid of coreceptor or other potential endogenous influences on the mode of recognition by the TCR. To select and stain the pMHC yeast, we created TCR tetramers by complexing C-terminally biotinylated TCR to streptavidin labeled with phycoerythrin (SA-PE). We first verified that an H2-L d platform containing the cognate peptide QL9 would be specifically recognized by recombinant QL9-specific TCR by using flow cytometry. Using an affinity-matured variant of 2C called m33 (Holler et al., 2003) , we observed bright peptide-dependent staining of yeast displaying Aga2-QL9-H2-L d ( Figure S1 ) (wild-type 2C TCR also showed positive staining). 42F3 tetramers poorly stained the same yeast population ( Figure S1 ); this indicates a weak affinity for this TCR-pMHC complex and is consistent with our SPR measurements ( Figure S1 ). We created three classes of libraries for yeast-displayed sc peptides-H2-L d . In the first, a random library consisted of peptides whose sequence was limited only to known anchor substitutions at the P2 and P9 anchor positions ( Figure 2B ) (Udaka et al., 2000) . All other positions were allowed full amino Immunity TCR-pMHC Docking Geometry Influences Signaling acid diversity by using a degenerate NNK nucleotide codon set. A second library randomized only ''up-facing'' TCR contact residues in the peptide based on the crystal structure (P4, P5, P7, and P8) ( Figures 1C and 2B ). A third library randomized ''down-facing'' MHC contact positions (P1, P2, P3, and P6) ( Figures 1C and 2B) .
After several rounds of enrichment by fluorescence activated cell sorting (FACS) with 42F3 tetramers (Figure S1 ), we recovered sequences of individual clones from the libraries that encoded diverse sets of peptides that were distinct from QL9 ( Figure 2C) . From the random library ( Figures 2C and Figure S1 ), we identified a single unique peptide sequence recognized by 42F3 ( Figures 2B and 2C ) that diverged from QL9 at every position. The TCR contact set encoded only conservative mutations at the P7 and P8 positions, whereas a new consensus arose at the P4 and P5 positions ( Figure 2C ). Encoded in the enriched MHC contact population were peptides that contained Trp at the P6 position and highly favored Asn at P3 ( Figure 2C ). We were surprised to find a Trp at P6, as it seemed incompatible with the pocket in the H2-L d groove that the Pro occupied in QL9 (discussed below). BLAST sequence searches indicate that none of the peptides discovered showed substantial similarity to known proteins.
In Vitro Validation of Library-Derived Peptides Binding to 42F3
We expressed the respective recombinant pMHC complexes and evaluated affinity by using surface plasmon resonance (SPR). Peptides selected from the combinatorial libraries bound to the recombinant 42F3 with affinities typical for TCR-pMHC interactions (K D $5-50 mM) and with very fast kinetics ( Figure S1 and Table S2 ). Only two of the tested pMHC complexes (3A1 and 5F1) ( Figure S1 and Table S2 ) exhibited fittable kinetics. All of the measured clones, including the random library clone 3A1, bound with higher affinity (K D $4 mM) to 42F3 than did the original agonist ligand presented by the sc QL9-H2-L d ( Figure 2C and Figure S1 ). These selected peptides provided a diverse collection of chemical features and affinities to assay for differences in signaling properties in a functional T cell assay.
T Cell Activation
We generated stable CD8 + and CD8 À 42F3 T cell hybridoma transfectants by using retroviral-mediated gene transduction. Antigen presenting cells (APCs) pulsed with five TCR contact peptides produced IL-2 in the presence or absence of CD8, consistent with their affinities and the affinity threshold (K D $1 to 5 mM) for CD8 independence (Chervin et al., 2009) (Figures 3A and 3B) . In contrast, the four MHC contact peptides tested and the native QL9 required CD8 for stimulating 42F3 T cells (Figures 3A and 3B) . Although this result is expected for the peptides QL9 and p5E8, which have lower affinities for the 42F3 TCR (K D $300 and 48 mM in the sc peptide-H2-L d format, respectively), the CD8 dependence was not expected for peptides p5F1 and p5F2, which had affinities for 42F3 equal to or better than the CD8-independent TCR contact peptides (Figure 2C) . It is possible that the binding to the cell surface H2-L d is reduced for the MHC contact peptides compared to the TCR contact peptides, and this property influences the requirement for CD8. Consistent with this notion, the TCR contact peptide p4B3 was active at low peptide concentrations in the presence of CD8 ( Figure S2A ). A peptide from the random library, SPLDSLWWI (p3A1), failed to induce a strong IL-2 response for either 42F3 T cell line up to a concentration of 100 mM peptide (Figures 3A and 3B and Figures S2B and 2C) , despite having one of the highest measured SPR affinities for the 42F3 TCR (Figures 2C and Figure S1) . To determine whether the lack of IL-2 stimulation was due to inefficient loading of p3A1 onto H2-L d on the APC, we assayed p3A1's ability to compete with a biotinylated agonist for MHC binding on the APC surface ( Figure S2A ). We labeled the biotinylated agonist with SA-PE and measured APC binding by using flow cytometry ( Figure S2D ). The unlabelled p3A1 peptide effectively competed for MHC binding on the APCs at experimental conditions (10 mM) comparably to several agonist peptides ( Figure ( Figure 3C ). Finally, we asked whether the lack of stimulation was due to an APL type of downstream antagonism that could inhibit the function of copresented agonist peptide (Hogquist et al., 1994; Stone et al., 2011) . However, agonist (p4B3)-induced activation was not influenced by the p3A1 peptide presented by the same APC ( Figure 3D ). The p3A1 peptide, then, binds to 42F3 with comparable affinity to agonists but does not appear to deliver either an activating or inhibitory signal.
2D Affinity and Tetramer Binding to Cells
Recently, kinetic measurements using intact T cells have been shown to correlate with proliferative T cell responses for the 5c.c7 and OT1 TCR systems (Huang et al., 2010; Huppa et al., 2010) . The advantage of this approach over 3D kinetic measurements such as SPR is that the membrane confinement properties of the TCR and pMHC are preserved. Because 3D kinetics of the 42F3 peptides poorly correlated with activation, we carried out experiments to measure the 2D kinetic parameters of p3A1-H2-L d binding to CD8ab À 42F3 T cells and compared it to several agonists ( Figure 4A and Figure S3 ). In this format, 42F3 transfectants are used as the source of TCR, and SA-coated red blood cells are decorated with the same N-terminally biotinylated sc peptide-H2-L d complexes used for SPR measurements. In situ, the agonist peptides bound to the T cells with fast A c k on and fast 2D-k off creating greater than two-fold difference in 2D affinity compared to p3A1 ( Figure 4A) , consistent with the IL-2 activation ( Figures 3A and 3B) . Although all measured peptides had fast off-rates (t 1/2 = 0.2-0.09 s), the p3A1-H2-L d interaction had the slowest 2D-k off ( Figure S3 ).
The rank orders of peptide affinities in the 2D format correlated better with peptide biological activity ( Figure 3 ) than affinities measured by 3D ( Figure 4B and Figure S3 ). Both the lack of 42F3 T cell activation and the weak 2D-A c k on ( Figure S3 ) suggest that p3A1 association with the 42F3 TCR is less favorable on the T cell surface compared to isolated TCR in solution.
We further investigated the reduced 2D affinity of the p3A1 interface by probing the epitope availability on the peptideloaded APCs and the 42F3 T cell line, respectively. 42F3 tetramers stain p3A1-loaded APCs ( Figure 4C ), whereas p3A1-H2-L d tetramers did not stain 42F3 T cells ( Figure 4D ). TCR tetramer staining is in good correlation with the 3D affinities measured by SPR ( Figure 4E ), whereas the pMHC tetramer binding correlated better with the 2D affinities ( Figure 4F ). Collectively, the 2D and tetramer staining experiments show that the engagement of 42F3 TCR on cells appears to be spatially constrained during engagement of p3A1 compared to agonist peptides. When the TCR was not presented in the context of a T cell membrane during 3D SPR measurements, either as a tetramer or monomer in solution, the binding affinities and kinetics of several agonist peptides and p3A1 were more similar ( Figure 4E ).
Structural Features of pMHC Recognition
We determined crystal structures of the 42F3 TCR bound to each of the four peptide-H2- Figure S4 , and Table S1 ). Each peptide was well defined in the electron density and presented a unique structural epitope and chemical surface to the TCR ( Figure 5A and Figure S4 ). In fact, the interaction chemistries of each of the four peptides with the 42F3 CDR3s were nearly entirely distinct, ranging from largely hydrophobic (p3A1 and QL9) to polar-hydrophobic (p5E8) to charged (p4B10), highlighting a remarkable ability of a single binding site to accommodate a range of structural chemistries ( Figure 5A ). Although we do not describe each interface here in detail, of particular note are unexpected conformations 
D PV P PV P P P PV P P P P PV P P P P PV P P P P P P PV P P P P P P P P P P P P P P P P P P P P P P P P 0 of the p5E8 and p3A1 peptides, which contain either a Trp or Leu substitution at P6, respectively (P6 is Pro in QL9) (Figure 2C) . In p5E8, the peptide backbone has flipped, such that P6-Trp is now an up-facing TCR contact instead of a down-facing MHC anchor, apparently because of a lack of space for the Trp side chain in the H2-L d peptide binding groove ( Figure 5A ). The p5E8 P5-Phe, a TCR contact in QL9, is flipped down into the MHC anchor pocket previously filled with the QL9 P6-Pro ( Figure 5A ). Thus, the TCR epitope of the MHC contact peptide is completely altered even though none of the TCR contact residues were randomized in this library. In the case of p3A1, the P6-Leu also becomes a TCR contact. However, the p3A1 peptide fails to fill the P6 pocket, instead forming an arched conformation ( Figure 5A and Figure S4 ). These observations highlight the unpredictable manifestations of peptide substitutions on T cell recognition and that MHC anchors can greatly impact the TCR epitope in unexpected fashions. Superposition of the four TCR structures from the complexes shows that CDR3 conformational variability in 42F3 primarily lies in CDR3a, not CDR3b (Figure 5B ). This illustrates TCR crossreactivity through a relatively rigid TCR binding site in the absence of significant CDR3b flexibility.
TCR-pMHC Docking Geometry
All three of the agonist peptides share a similar overall docking footprint where the Va and Vb are positioned diagonally across the surface of the pMHC ( Figure 6A ). In contrast, the nonstimulatory p3A1 docking footprint diverged markedly ( Figures 6A and  7A ). In the agonist complexes, comparison of the Va3.3 contact points with the a2 helix revealed the same conserved contact set previously observed for four 2C complexes with agonist peptides (Figures 1D and 6B) involving Va germline residues Lys48a, Tyr31a, Tyr50a, and Ser51a ( Figure 6C and Figure S5 ). Through small-scale rolling and tilting adjustments of the TCR in each complex, Va3.3 formed a variety of auxiliary polar and Immunity TCR-pMHC Docking Geometry Influences Signaling van der Waals contacts unique to each pMHC's interface while retaining a shared core of contacts ( Figure 6C and Figure S5 ). For example, a C-terminal roll in the QL9 complex allowed Lys48a to hydrogen bond to the MHC a2 backbone, whereas in the p4B10 complex, the Va makes additional hydrogen bonds from Tyr50a and Ser51a to the Glu154 carboxyl group (Figure S5 ). These adjustments show that the Va germline contacts adapt to peptide-specific sequence differences while maintaining a strikingly conserved contact set with the MHC a2 helix ( Figures 6B and 6C ). This peripheral plasticity in the midst of a conserved core interaction network was also noted for the Vb8/I-A complexes Feng et al., 2007) .
The structures show that 42F3 Vb8, which appeared to have key germline contacts in prior Vb8 complexes, does not form Figure S5 ). Although Tyr50b and Asn31b continue to play prominent roles in each of these interfaces, and the overall location of the Vb-MHC contact patch is very similar between the structures ( Figure 6B ), the pairwise contacts are chemically distinct ( Figure S5 ). The residue Tyr50b, central to the previously described Vb8.2-I-A ''codon'' (Feng et al., 2007) , uses a variety of side-chain rotamers to recognize the different pMHC surfaces ( Figure S5 ). In the p5E8 complex, the Tyr50b rotamer lies planar to the a1 helix as seen in the 2C-QL9-H2-L d complex ( Figure S5 ). In the QL9 and p4B10 complexes, Tyr50b points deep into the peptide binding groove to make a hydrogen bond to peptide at the P8-Asp position (Figure S5) . These structures highlight the important role and remarkable ability of Tyrosine residues in TCR V-regions to form multifarious germline MHC contacts (Garcia et al., 2009; Marrack et al., 2008) . Figure 6C ). Tyr31a and Tyr50a are among the most energetically important in the 2C TCR interaction with QL9-H2-L d (Manning et al., 1998) . The Va3.3 interaction motif accommodates slight differences in TCR roll and tilt, a variety of CDR3 sequences (2C, m6, m67, m13, and 42F3), and considerable peptide variation (QL9, pB10, and pE8) (Figure 6C) . We conclude that 2C and 42F3 TCR germline recognition of H2-L d is centered on a Va-centric ''codon,'' as compared to the apparently Vb-centric recognition of the class II I-A complexes ( Figure 6C ). It appears that different TCR complexes can be more or less Va-or Vb-centric in the utilization of conserved germline contacts. Figure 7B and Figure S5 ). The parallel docking topology also enables Vb8.3 to straddle the groove, with contacts on both the a1 and a2 helices, including Tyr50b interacting with the a2-helix. (Figure 7B and Figure S5 ). Also, a slightly squeezed conformation of p3A1 peptide binding groove results in a narrower distance between a1 and a2 helices, facilitating Asn31b bridging the MHC groove to form a bifurcated hydrogen bond with both Thr80 of the H2-L d a1 and Lys146 of a2 helices ( Figure 7B ).
The docking footprint appears to be at the extreme clockwise end of the range compared to other class I agonist TCR-pMHC complexes ( Figure 7C ). Importantly, despite the unusual MHC footprint, 42F3 CDR3a and CDR3b are focused on the peptide, and the global polarity of the complex does not violate the previous paradigm of Va lying over the N-terminal end of the groove and Vb lying over the C-terminal end ( Figures 5A and 7A ).
DISCUSSION
In a classical study, Janeway and colleagues showed that different TCR and CD3 antibodies had varied agonistic properties, prompting the suggestion that TCR signaling was dependent upon the overall architecture of the TCR-CD3 complex (Janeway, 1995; Yoon et al., 1994) . In contrast, other studies, such as those using chemically defined oligomerization agents concluded that intermolecular proximity alone was the key determinant for TCR activation (Cochran et al., 2001 ). Here we developed a peptide-based approach to investigate the interrelationship between TCR-pMHC binding chemistry, docking geometry, 2D and 3D binding parameters, and signaling. Our principal findings are that (1) not every binding orientation is compatible with signaling and (2) a TCR utilizing entirely distinct chemistries to recognize different peptides exhibits highly persistent germline-mediated contacts. That alternative TCR-MHC binding modes are accessed by certain peptides is an important extension to prior studies on TCR crossreactivity where the germline MHC contacts have largely remained intact, albeit often undergoing adjustments (Borbulevych et al., 2009; Ding et al., 1999; Garcia et al., 1998; Macdonald et al., 2009; Reiser et al., 2003; Wucherpfennig et al., 2009; Yin and Mariuzza, 2009 ). Here, we find that peptide crossreactivity can influence signaling through gross alterations of TCR binding geometry. What is the mechanistic basis for the p3A1 lack of activity? We do not know whether the manifestation of an altered TCR docking topology as a lack of signaling is reflective of conformational change(s), altered CD3 associations, clustering, or other events known to be critical for TCR signaling (van der Merwe and Dushek, 2011; Gil et al., 2002; Minguet et al., 2007) . Although not providing detailed answers, the 2D versus 3D experiments are informative. The 2D method clearly demonstrated that p3A1-H2-L d is binding to the 42F3 TCR on the cell surface, albeit with lower 2D affinity than the agonist peptides. The p3A1-H2-L d bound with high affinity to soluble monomeric 42F3 by using SPR (3D), but neither p3A1-H2-L d tetramers or p3A1-loaded dimers (H2-L d -Ig) stained or stimulated 42F3 T cells, respectively. Thus, when cellular spatial constraints are absent, there is a high affinity interaction between p3A1-H2-L d and 42F3, yet each of the three constrained methods yielded reduced signaling and binding by p3A1 versus a panel of agonist peptides. Collectively, these 2D and 3D data suggest that the spatial orientation of the prebound states of the TCR and pMHC on the cell membrane are critical factors determining TCR-MHC associations and TCR signaling.
We can propose several speculative but equally plausible models for p3A1's lack of activity. In one, in order for the TCR to engage in the unusual H2-L d docking angle on the APC, it is required to twist out of a signaling productive oligomeric or ultrastructural arrangement ( Figure 7D ). The docking angle in the p3A1 complex may have exceeded the allowable range of signaling competent binding modes. The minimal signaling TCR ligand is a pMHC dimer (Boniface et al., 1998; Cochran et al., 2001) , and a study proposed a specific topology of the corresponding ab-TCR-CD3 dimer (Kuhns et al., 2010) . Engagement of p3A1 may either produce unproductive TCR-pMHC dimers or inhibit, or poison, the formation of productive p3A1 dimers by blocking the recruitment of a second TCR or MHC, the latter scenario being an oligomer exclusion model ( Figure 7D ). In short, the p3A1 docking topology may be incompatible with the TCR-CD3 signaling dimer architecture ( Figure 7D ). However, we currently know very little about the ultrastructure of clustered TCR and how these geometric considerations influence the engagement of distinct pMHC orientations. Because the majority of class I MHC on the APC surface present selfpeptides, it is rare for a T cell receptor dimer to encounter two foreign agonist peptides in MHC simultaneously. Rather, T cells can apparently overcome this limitation by signaling via an MHC pseudodimer containing only one agonist peptide, but whether there are geometric constraints placed upon agonist signaling by the endogenous coagonist is not known (Juang et al., 2010) . Unclustering the TCR by disrupting lipid rafts or actin polymerization has been shown to change the 2D affinity for TCR-pMHC (Huang et al., 2010; Huppa et al., 2010) , Immunity TCR-pMHC Docking Geometry Influences Signaling suggesting an important role for TCR membrane organization in antigen recognition. It is also possible that simultaneous, multipoint attachment of CD3, CD8, and MHC to the TCR within a unitary signaling complex in these signaling clusters can occur only within a range of TCR-pMHC docking angles that are accommodated by canonical orientations. The p3A1 docking angle may have exceeded these tolerances so that in order for 42F3 to bind to p3A1, either the signaling competent TCR dimer or oligomer or its associations with coreceptors (CD3, CD4 or CD8) are disrupted. It is puzzling that although the association of p3A1 was weaker in situ than agonists, the resulting 2D A c K a , A c k on , and k off were equivalent to that of stimulatory pMHC associations on OT1 CD8 + T cells (Huang et al., 2010) .
Thus, the lack of activation is not fully explained by decreased 2D kinetics alone. That the nonstimulatory peptide is not a naturally occurring sequence, and binds in an unconventional orientation, has potential implications for the notion of germline TCR-MHC coevolution. Germline specificity presumably evolved in the context of coreceptors and natural peptide antigen sequences, contributing to productive TCR-MHC-CD3-CD8 (or CD4)-signaling geometries. p3A1, being an unnatural peptide could have accessed geometric limits of TCR-pMHC orientation Figure S5 .
incompatible with signaling on T cells. In this respect, the synthetic approach may sidestep evolutionary pressures experienced in the context of the endogenous peptide milieu to achieve an unnatural docking footprint. However, it is unclear whether the docking mode we see for p3A1 is germline-encoded, or not, because the overall canonical binding polarity is not violated compared to other TCR-pMHC complexes, and important germline residues (e.g., Tyr31a, Tyr51a, Tyr50b) still mediate the MHC contacts. It is intriguing to consider that nonproductive peptides and binding modes analogous to p3A1 could exist in nature but have evaded experimental detection using TCR-signaling-based identification methods.
With reference to prior studies showing conserved germline Vb8.2-I-A contacts in over eight TCR-pMHC complexes, the Va3.3 and Va3.1 recognition of H2-L d shown here for seven different agonist peptide complexes (42F3 and 2C) illustrates that both Vb-and Va-centric germline motifs, which we have euphemistically referred to as ''codons,'' exist. In the case of H2-L d , the Va codon centers on MHC position 155, which has been previously identified as a component of the MHC restriction triad, and is contacted in nearly all class I TCRpMHC complex structures (Tynan et al., 2007) , highlighting the astonishing ability of each V segment to form structurally distinct sets of contacts with different classes of MHC. Such diversity appears conserved within a given MHC but very different across different MHC.
Immunity
TCR-pMHC Docking Geometry Influences Signaling
On the one hand, elucidation of an alternative docking mode suggests that peptides can influence the TCR to form dissimilar germline contacts with MHC. On the other hand, three of the four peptides are recognized in a convergent and apparently germline-encoded Va docking position. That this convergence was achieved with distinct peptides selected in the absence of coreceptors strongly supports the influence of an intrinsic MHC specificity. We suggest these seemingly incongruent results are consistent and reconcile the relative roles of intrinsic (germline engrafted specificity) and extrinsic (steric influence of coreceptors) in positioning the TCR-MHC docking orientation. Germline TCR-MHC specificity probably arose within the context of a higher order TCR-CD3-MHC-CD8 (or CD4) complex where the TCR was positioned topologically, through multipoint attachment, for productive signaling. In this sense, the interfacial TCR-MHC contacts mediating signaling competent binding geometries have been selected during evolution. These higher order geometric constraints would certainly involve coreceptor influences that could enforce the invariant TCR-MHC docking polarity. However, this interfacial specificity was engrafted in the germline, which obviated the need for coreceptors to actively position the TCR. Taken together, our data demonstrate a relationship between TCR-MHC docking geometry, peptide crossreactivity, germline bias, and signaling. The innate crossreactivity of T cell recognition is apparently more than a means of simply enabling a structurally agnostic bimolecular interaction between a TCR and MHC. Rather, the chemistry of the peptide can modulate docking footprints as well as kinetics and affinity, which in turn can modulate signaling. Our future studies will attempt to more deeply understand the generality and ultrastructural mechanism of this unexpected finding.
EXPERIMENTAL PROCEDURES
Cloning and Expression of 42F3 TCR RNA was isolated from primary 42F3 T cells in order to prepare cDNA of the TCR a and b chains. For recombinant expression, the V regions of the a and b chain were spliced by overlapping extension to form a Va-(Gly 4 Ser) 4 -Vb scFv expressed in pET22b to allow for periplasmic secretion. Two stabilizing mutations in the Va3.3 and five mutations in the Vb8.3 were introduced as previously described for 2C (Colf et al., 2007) . For full-length ectodomains, the wt Va3.3 and Vb8.3 regions of the 43F3 TCR were fused in frame with human constant domains (Boulter et al., 2003) and expressed in baculovirus with a C-terminal acidic GCN4 zipper-BAP-6xHis tag (a) or a C-terminal basic GCN4-zipper-6xHis tag (b). 
42F3 Tetramer Selection of Yeast Clones
After induction of the yeast libraries, the yeast cells were incubated with 470 nM preformed 42F3 tetramers assembled on SA-PE (Invitrogen) and 1:100 dilution of anti-HA-Alexa488 (Invitrogen) sorted on a FACS Aria (BD). During the first round of selections, the brightest 2.5% of the TCR-Tet+/HA+ population was sorted into a single culture. The sorted cells were grown overnight and the process repeated. After the first round of selection, the brightest 1% of TCR-Tet+/HA+ was sorted until greater than 10% of the yeast population could be resolved from the unstained population by flow cytometry.
2D Kinetics Measurements
Procedures for coupling pMHC to red blood cells (RBC) or glass beads have been described (Huang et al., 2007) . Briefly, RBCs were first biotinylated with biotin-X-NHS (EMD chemicals) and then reacted to streptavidin; borosilicate beads were first cleaned, silanized, and then reacted to streptavidin-maleimide (Sigma-Aldrich, St. Louis, MO). Streptavidinized RBC or beads were finally coupled to the sc pMHC through their biotin tags. Site densities of TCR on hybridoma cells and pMHC on RBC or bead surfaces were measured with flow cytometry. Micropipette adhesion frequency assay and thermal fluctuation assay were carried out in a similar manner as previously described (Chesla et al., 1998) and described in detail in Supplemental Experimental Procedures.
Additional Methods
More detailed descriptions of methods for protein expression and purification, SPR measurements, protein crystallization and structure refinement, T cell activation assays, and MHC-TCR tetramer staining can be found in the Supplemental Information.
ACCESSION NUMBERS
Atomic coordinates have been deposited in the Protein Data Bank under the accession numbers 3TPU, 3TJH, 3TFK, and 3TF7 for the 42F3-p5E8, 42F3-p3A1, 42F3-p4B10, and 42F3-QL9 TCR-pMHC complexes, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, five figures, and two tables and can be found with this article online at doi:10.1016/j.immuni.2011.09.013.
